World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
31967
World Ranking
10098
National Ranking
5201

Overview

Gregory H. Reaman is affiliated with the US Food and Drug Administration in the United States. Their research primarily spans the field of Medicine, with significant contributions to Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Oncology, Neurology, and Molecular Biology.

The scientist's work addresses various specialized topics including:

  • Childhood Cancer Survivors' Quality of Life
  • Pharmaceutical studies and practices
  • Acute Lymphoblastic Leukemia research
  • Neuroblastoma Research and Treatments
  • CAR-T cell therapy research
  • Ethics and Legal Issues in Pediatric Healthcare
  • Statistical Methods in Clinical Trials

Frequently collaborating with other researchers, their notable co-authors include Dominik Karres, Gilles Vassal, Andrew D.J. Pearson, Malcolm A. Smith, and Nicole Scobie, each having contributed in multiple joint publications.

Gregory H. Reaman has published extensively in leading journals, with frequent appearances in:

  • European Journal of Cancer
  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • JNCI Journal of the National Cancer Institute
  • Clinical Pharmacology & Therapeutics

Their selected recent papers represent a focus on pediatric oncology and drug development, including:

  • FDA Approval Summary: Selumetinib for Plexiform Neurofibroma, 2021, Clinical Cancer Research
  • ACCELERATE and European Medicines Agency Paediatric Strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients, 2020, European Journal of Cancer
  • Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies, 2021, European Journal of Cancer
  • ACCELERATE - Five years accelerating cancer drug development for children and adolescents, 2022, European Journal of Cancer
  • Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents, 2020, European Journal of Cancer

In addition to journal articles, Gregory H. Reaman has contributed to book publications, including the 2022 title Pediatric Cancer Therapeutics Development published by Springer International Publishing.

Best Publications

  • Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

    Charles G Mullighan;Xiaoping Su;Jinghui Zhang;Ina Radtke

  • Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First Century

    Malcolm A. Smith;Nita L. Seibel;Sean F. Altekruse;Lynn A.G. Ries

  • Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group

    Stephen P. Hunger;Xiaomin Lu;Meenakshi Devidas;Bruce M. Camitta

  • Genetic Alterations Activating Kinase and Cytokine Receptor Signaling in High-Risk Acute Lymphoblastic Leukemia

    Kathryn G. Roberts;Ryan D. Morin;Jinghui Zhang;Martin Hirst

  • High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group

    Smita Bhatia;Yutaka Yasui;Leslie L. Robison;Jillian M. Birch

  • Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

    Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;I-Ming Chen;I-Ming Chen;Walker Wharton

  • JAK mutations in high-risk childhood acute lymphoblastic leukemia.

    Charles G. Mullighan;Jinghui Zhang;Richard C. Harvey;J. Racquel Collins-Underwood

  • Declining childhood and adolescent cancer mortality.

    Malcolm A. Smith;Sean F. Altekruse;Peter C. Adamson;Gregory H. Reaman

  • Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome.

    Richard C. Harvey;Richard C. Harvey;Charles G. Mullighan;Xuefei Wang;Kevin K. Dobbin

  • American Society of Clinical Oncology Statement: Achieving High-Quality Cancer Survivorship Care

    Mary S. McCabe;Smita Bhatia;Kevin C. Oeffinger;Gregory H. Reaman

  • Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.

    Donald A. Berry;Shouhao Zhou;Howard Higley;Lata Mukundan

  • Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood

    R J Packer;B Lange;J Ater;H S Nicholson

  • Recombinant Urate Oxidase for the Prophylaxis or Treatment of Hyperuricemia in Patients With Leukemia or Lymphoma

    Ching-Hon Pui;Hazem H. Mahmoud;Joseph M. Wiley;Gerald M. Woods

  • Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group

    Stacey L. Berg;Susan M. Blaney;Meenakshi Devidas;Tom A. Lampkin

  • Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group.

    Joanne M. Hilden;Patricia A. Dinndorf;Sharon O. Meerbaum;Harland Sather

  • Progress in Childhood Cancer: 50 Years of Research Collaboration, A Report from the Children's Oncology Group

    Maura O'Leary;Mark Krailo;James R. Anderson;Gregory H. Reaman

  • Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.

    Jinghui Zhang;Charles G. Mullighan;Richard C. Harvey;Gang Wu

  • The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA

    Philipp Kapranov;Georges St Laurent;Georges St Laurent;Tal Raz;Fatih Ozsolak

  • Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and out come prediction in pedeatric b-precursor acute lymphoblastic leukemia

    Cheryl L. Willman;Richard Harvey;Huining Kang;Edward Bedrick

  • Early Response to Therapy and Outcome in Childhood Acute Lymphoblastic Leukemia A Review

    Paul S. Gaynon;Anish A. Desai;Bruce C. Bostrom;Raymond J. Hutchinson

Frequent Co-Authors

Paul S. Gaynon
Paul S. Gaynon University of Southern California
Harland N. Sather
Harland N. Sather University of Southern California
David G. Poplack
David G. Poplack Baylor College of Medicine
Ching-Hon Pui
Ching-Hon Pui St. Jude Children's Research Hospital
Diane C. Arthur
Diane C. Arthur National Institutes of Health
Paul A. Bunn
Paul A. Bunn University of Colorado Boulder
Mark E. Nesbit
Mark E. Nesbit University of Minnesota
Mike Clarke
Mike Clarke Queen's University Belfast
Stephen E. Sallan
Stephen E. Sallan Harvard University
John H. Kersey
John H. Kersey University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens the door to a range of related health and science careers. Today, flexible online programs make it easier than ever to pursue these paths while balancing work and personal commitments.

For those interested in promoting health and wellness, an online bachelor's in nutrition can lead to diverse roles in healthcare, counseling, or food science. If your ambitions are in healthcare leadership, cahme accredited online mha programs offer rigorous training in administration and management, fully online and widely respected in the industry.

Nurses seeking to upgrade credentials may consider the best online rn to bsn programs without clinical requirements, which provide a convenient pathway to advancement without in-person practicum. For experienced nurses aiming for the highest clinical roles, a 1 year dnp program online offers expedited, doctoral-level training that can dramatically enhance career opportunities.

Each of these online programs offers flexibility, streamlined coursework, and targeted expertise, helping you position yourself for a rewarding career in healthcare or allied fields.

Best Scientists Citing Gregory H. Reaman

Trending Scientists